Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

COUCH Medcomms

- PMLiVE

Roche presents positive results for spinal muscular atrophy treatment Evrysdi in babies

The progressive neuromuscular disease affects approximately one in every 10,000 babies

- PMLiVE

Nanobiotix shares promising results for radiotherapy enhancer in advanced pancreatic cancer

More than 90% of patients with locally advanced disease are not eligible for surgery

- PMLiVE

BioIndustry Association reveals how UK is set to become a global leader in mRNA

Several companies and organisations have supported the development of mRNA

The AI Roadmap – charting our future in healthcare communications

The HCA has published a new position paper on the use of AI within the sector

- PMLiVE

Executive Insight Healthcare Consultants promotes Philippe Coune to partner

Coune first joined the company in 2013 as a consultant

- PMLiVE

Harnessing the power of AI in clinical trials

Fareed Melhem talks about how artificial intelligence can help to reduce the burden of trials on patients

- PMLiVE

Learning from the best: seven steps to exceptional launches

Repurposing ‘YOLO’ to stand for ‘You Only Launch Once’

Top 10 benefits of virtual advisory boards: Increased Engagement and Insights

#2. Increased Advisor Engagement and Quality and Quantity of Insights

Impetus Digital

- PMLiVE

Sandoz separates from Novartis as an independent spin-off company

The split allows Sandoz to strengthen its position in generics and biosimilars

- PMLiVE

Moderna’s COVID-19/flu combination vaccine shows promise in phase 1/2 study

The approach could simplify immunisation practices and lead to higher vaccine uptake

- PMLiVE

International study reveals 11 new genes linked to aggressive prostate cancer

Findings from the study could improve treatment options for patients with prostate cancer

- PMLiVE

New vaccine technology could help fight future viruses and variants

The antigen technology could enhance vaccine protection against potential threats

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links